When it comes to the progression seen in brain cancer, there are many different details to look into. What are the ones which seem to be the most common, you may wonder? How exactly will certain drugs be reacted to when they are implemented for the sake of helping patients in this regard? From what has been, apparently a mechanism linked to this level of growth has been seen and it has the potential to be one that can help in the various research efforts to come.
Companies such as Voices against Brain Cancer know how vital this condition is and why it is important for research to be conducted. Brain cancer will be focused on and one of the reasons for this is because of its various components, which are what play into the complex nature of various tumors. An article on Medical Xpress attested to the idea that the focus is greatly placed on glioma, which is viewed as the most aggressive type of cancer in this regard. The written report also made mention of assistance given by an FDA-approved food additive.
Medical Xpress spoke about how this food additive was surveyed by two individuals: professor of the University of Vermont Diane M. Jaworski, Ph.D., and Patrick Long, who is a former graduate of the institution. Their attention was placed on an enzyme by the name of aspartoacylase. What this does is break down another compound called N-acetyl-L-aspartate. For those who are unaware, NAA is the primary storage form of acetate seen in the brain. In general, it is able to turn genes on as well as off. In regards to glioma, NAA levels and ASPA expression are lowered.
It seems as though there were various efforts done in order to help increase the levels of ASPA expressions but the article said that, unfortunately, proliferation resulted from it. However, the report made mention of a food additive to be utilized later on and it was called glyceryl triacetate. Not only would this potentially be able to help glioma patients but it has been implemented in order to assist patients with Canavan disease as well. This is an inherited condition that results in brain cell damage.
According to the article, GTA was put to use and the results that came to surface were rather positive. It showed lower levels of growth in terms of glioma stem cells but another positive to consider was that the healthy cells remained unharmed. This, to me, is the most important factor to consider about this condition. It shows that there is a level of potential to consider, especially when considering that toxicity and side-effects alike are practically nonexistent with GTA being put to use for research purposes.
Companies such as Voices against Brain Cancer know how vital this condition is and why it is important for research to be conducted. Brain cancer will be focused on and one of the reasons for this is because of its various components, which are what play into the complex nature of various tumors. An article on Medical Xpress attested to the idea that the focus is greatly placed on glioma, which is viewed as the most aggressive type of cancer in this regard. The written report also made mention of assistance given by an FDA-approved food additive.
Medical Xpress spoke about how this food additive was surveyed by two individuals: professor of the University of Vermont Diane M. Jaworski, Ph.D., and Patrick Long, who is a former graduate of the institution. Their attention was placed on an enzyme by the name of aspartoacylase. What this does is break down another compound called N-acetyl-L-aspartate. For those who are unaware, NAA is the primary storage form of acetate seen in the brain. In general, it is able to turn genes on as well as off. In regards to glioma, NAA levels and ASPA expression are lowered.
It seems as though there were various efforts done in order to help increase the levels of ASPA expressions but the article said that, unfortunately, proliferation resulted from it. However, the report made mention of a food additive to be utilized later on and it was called glyceryl triacetate. Not only would this potentially be able to help glioma patients but it has been implemented in order to assist patients with Canavan disease as well. This is an inherited condition that results in brain cell damage.
According to the article, GTA was put to use and the results that came to surface were rather positive. It showed lower levels of growth in terms of glioma stem cells but another positive to consider was that the healthy cells remained unharmed. This, to me, is the most important factor to consider about this condition. It shows that there is a level of potential to consider, especially when considering that toxicity and side-effects alike are practically nonexistent with GTA being put to use for research purposes.
About the Author:
For extra information about brain cancer and how you can help, go to Voices against Brain Cancer.
No comments:
Post a Comment